Lenz & Staehelin advised the City of Geneva on the issuance. The City of Geneva issued a green bonds for an aggregate principal amount of CHF 140...
City Of Geneva’s CHF140 Million Green Bonds Issuance
Vencora UK Ltd’s Public Tender Offer For Shares of Crealogix Holding AG
Homburger AG advises Vencora and CSI while Lenz & Staehelin advised CREALOGIX in this transaction. Vencora UK Limited, an indirect subsidiary of Volaris Group Inc. and...
Basilea Pharmaceutica’s Asset Purchase Agreement With Amplyx Pharmaceuticals
Lenz & Staehelin is advising Pfizer and Amplyx Pharmaceuticals on this transaction. Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, entered into an asset purchase agreement with Amplyx Pharmaceuticals,...
Starrag Group’s Merger With Tornos
Lenz & Staehelin advised Starrag Group Holding AG and Tornos Holding AG on their merger. The two traditional Swiss precision machine tool manufacturers Starrag and Tornos,...
Nordic BioSite’s Acquisition of LubioScience
Lenz & Staehelin has advised Nordic BioSite Group in this acquisition; Wenger Plattner acted for LubioScience. Nordic BioSite Group, a portfolio company of Adelis Equity Partners, has acquired LubioScience,...
MKS Pamp Group’s Strategic Investment in APMEX
Lenz & Staehelin acted as lead counsel to the MKS PAMP GROUP. MKS PAMP GROUP – a leading provider of refining, supplying and trading of precious...
Latour Capital’s Acquisition of Gutor
Lenz & Staehelin advised Latour Capital on the Swiss legal aspects of this transaction and its financing, with Cleary Gottlieb being lead counsel. Latour Capital successfully...
Chiesi Farmaceutici S.p.A.’s Acquisition of Raxone/idebenone From Santhera Pharmaceuticals AG
Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the operation. Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the sale of its Raxone®/idebenone business for all...
Elos Medtech’s Acquisition of Klingel Medical Group
Renzenbrink & Partner advised IK Partners on the deal while McDermott Will & Emery and Lenz & Staehelin represented Elos Medtech. IK Partners announced the sale...
NewGAMe’s Partial Cash Tender Offer on GAM Holdin AG’ Shares
Lenz & Staehelin advises NewGAMe SA on its tender offer and continues to advise the investor group on its shareholding in GAM. NewGAMe SA announced the...
International Finance Facility for Education (IFFEd)’s Become an Independent Organization
Lenz & Staehelin assisted in the creation of the International Finance Facility for Education (IFFEd), a Geneva-based non-profit foundation which has officially become a fully independent...
Mastercard’s Competition Commission Investigation on Interchange Fees
Lenz & Staehelin represents Mastercard in the Competition Commission investigation on interchange fees. The Swiss Competition Commission (“ComCo”) opened an investigation into Mastercard’s domestic interchange fees...